These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2645558)

  • 1. [The role of bone scintigraphy and its value in the staging and follow up of prostatic carcinoma].
    Adám E; Gervain M; Rajtár M; Oszlánczi J; Csernay L; Scultéty S
    Orv Hetil; 1989 Feb; 130(7):335-40. PubMed ID: 2645558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
    Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
    Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer of the prostate: value of bone scintigraphy. Point of view].
    Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
    Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The usefulness of early whole body bone scintigraphy in the detection of bone metastasis from prostatic cancer].
    Otsuka N; Fukunaga M; Furukawa Y; Tanaka H
    Kaku Igaku; 1994 Jun; 31(6):541-50. PubMed ID: 7520953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups.
    Koizumi M; Motegi K; Koyama M; Terauchi T; Yuasa T; Yonese J
    Ann Nucl Med; 2017 Aug; 31(7):521-528. PubMed ID: 28456877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical value of bone scintigraphy in the diagnosis of prostatic neoplasm metastases].
    Sintermann R; Langhammer H
    Med Welt; 1979 Jun; 30(24):929-312. PubMed ID: 459815
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer.
    Langhammer H; Sintermann R; Hör G; Pabst HW
    Nuklearmedizin; 1978 Jul; 17(3):87-91. PubMed ID: 568257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scintigraphic evaluation of the skeleton in multiple myeloma.
    Wahner HW; Kyle RA; Beabout JW
    Mayo Clin Proc; 1980 Dec; 55(12):739-46. PubMed ID: 7218877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is bone scan useful in patients with breast cancer localized on the basis of clinical examination. 143 cases (author's transl)].
    Stines J; Stalars J; Dartois D; Chardot C
    Bull Cancer; 1980; 67(3):319-23. PubMed ID: 7407430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "super" bone scan.
    Higginbotham EA
    J Natl Med Assoc; 1980 Mar; 72(3):291-4. PubMed ID: 7392072
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bone metastases of prostatic neoplasms with reference to the histological type and local tumor stage].
    Langerhammer H; Steuer G; Gradinger R; Sintermann R; Pabst HW
    Schweiz Med Wochenschr; 1980 Jan; 110(1):11-5. PubMed ID: 6244617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on prognosis of prostate cancer with bone metastasis by using pretreatment bone scintigraphy].
    Kubota Y; Numasawa K; Suzuki H; Kakizaki H; Suzuki K
    Hinyokika Kiyo; 1989 Oct; 35(10):1693-9. PubMed ID: 2610178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial bone scanning in the evaluation of stage and clinical course in carcinoma of the prostate.
    Johansson JE; Beckman KW; Lindell D; Lingårdh ; Rydman H; Vikterlöf KJ
    Scand J Urol Nephrol Suppl; 1980; 55():31-6. PubMed ID: 6938033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The staging of M1 disease: the role of bone scan, Xray and other imaging techniques.
    Richards B; Bollack C; Bouffioux C
    Prog Clin Biol Res; 1988; 269():233-42. PubMed ID: 3293062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal scintigraphy for routine surveillance of M0 prostatic carcinoma.
    Carter SS; Hilson AJ; Constable AR; Lewis CA; Shah PJ; O'Donoghue EP
    Contrib Nephrol; 1987; 56():267-72. PubMed ID: 3608500
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of follow-up bone scans in carcinoma of the prostate.
    Corrie D; Timmons JH; Bauman JM; Thompson IM
    Cancer; 1988 Jun; 61(12):2453-4. PubMed ID: 3130180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
    Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
    Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
    Goodman CM; Cumming JA; Ritchie AW; Chisholm GD
    Br J Urol; 1991 Jun; 67(6):622-5. PubMed ID: 2070208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of urinary time in bone scintigraphy in the evaluation of renal function. Apropos of 57 cases of cancer of the prostate].
    Amiel J; Quintens H; Lapalus F; Raymond G; Toubol J
    J Urol (Paris); 1987; 93(8):467-8. PubMed ID: 3440839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Staging in prostate carcinoma].
    Trinkler FB; Böni RA; Krestin GP
    Ther Umsch; 1995 Jun; 52(6):399-404. PubMed ID: 7604393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.